Clinical trial
Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects
NCT05902728 is registered in ClinicalTrials.gov with Shanghai Henlius Biotech as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects
- Lead sponsor
- Shanghai Henlius Biotech
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 4, 2023
- Completion date
- December 19, 2023
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nsclc